Rapporto sull’analisi delle dimensioni del mercato e delle quote del mercato Diagnostica di precisione | Previsioni 2031

  • Report Code : TIPRE00029425
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 150
Buy Now

[Rapporto di ricerca] Si prevede che il mercato della diagnostica di precisione raggiungerà i 168.405,71 milioni di dollari entro il 2028 rispetto ai 79.776,88 milioni di dollari del 2022; si prevede che crescerà a un CAGR del 13,3% dal 2022 al 2028.

La diagnostica di precisione è metodi di diagnosi delle malattie che spiegano le condizioni del paziente in modo dettagliato e preciso. Aiuta gli operatori sanitari a eseguire le procedure di trattamento in modo efficace ed efficiente. Viene utilizzato per curare il diabete, il cancro e altri disturbi utilizzando vari test, inclusi test esoterici, test genetici e altri.

Il mercato della diagnostica di precisione è segmentato in base al tipo, all'applicazione, all'utente finale, e geografia. Per geografia, il mercato è segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Asia. Africa e SAM Il rapporto sul mercato della diagnostica di precisione offre approfondimenti e analisi approfondite del mercato, sottolineando parametri tra cui dimensioni del mercato, tendenze, progressi tecnologici e dinamiche di mercato. Fornisce inoltre l’analisi del panorama competitivo dei principali attori del mercato in tutto il mondo. Inoltre, il rapporto include l'impatto della pandemia COVID-19 sul mercato della diagnostica di precisione in tutte le regioni.

Approfondimenti strategici

La crescita del mercato della diagnostica di precisione è attribuita al un numero crescente di studi in corso per sviluppare un nuovo trattamento contro il cancro e iniziative governative per creare consapevolezza sulla diagnostica di precisione tra gli operatori sanitari della comunità. Tuttavia, i costi elevati associati alla diagnosi e alla medicina di precisione limitano la crescita del mercato.

Regioni redditizie per il mercato della diagnostica di precisione

Approfondimenti di mercato
Applicazioni in crescita in oncologia e altre patologie guida la crescita del mercato della diagnostica di precisione

Il concetto di medicina di precisione viene applicato in modo efficace nella cura delle malattie rare. Sebbene sia più popolare in oncologia, si sta gradualmente diffondendo anche ad altre specialità. La crescente prevalenza del cancro e la crescente incidenza di disturbi neurologici rari stanno aumentando la domanda di medicina di precisione, che sta guidando la crescita del mercato globale della diagnostica di precisione. Inoltre, secondo la Neurological Alliance, nel 2019 sono stati registrati circa 14,7 milioni di casi neurologici, con almeno 1 persona su 6 affetta da una o più condizioni neurologiche. Secondo il National Cancer Institute, si prevede che il numero di nuovi casi di cancro salirà a 29,5 milioni entro il 2040, con un aumento dei decessi correlati al cancro di 16,4 milioni. Secondo l’Organizzazione Mondiale della Sanità (OMS), la malattia di Alzheimer, la forma più comune di demenza, contribuisce a quasi il 60-70% dei casi. Inoltre, a settembre 2021, più di 55 milioni di persone convivono con demenza in tutto il mondo, con quasi 10 milioni di nuovi casi all’anno. Inoltre, la crescente domanda di procedure terapeutiche in oncologia e altri disturbi sta incrementando l'adozione di procedure terapeutiche.

Inoltre, il numero crescente di collaborazioni strategiche tra aziende biofarmaceutiche per sviluppare farmaci mirati a trattare un gruppo specifico di pazienti in base alle loro esigenze specifiche e per fornire procedure e servizi terapeutici efficaci sta aumentando il numero di studi clinici. Ad esempio, Personal Genome Diagnostics Inc. e Massachusetts General Hospital hanno collaborato per promuovere lo sviluppo di servizi terapeutici efficaci nel 2021. Nell'aprile 2022, viene formato il Precision Cancer Consortium (PCC) come nuova collaborazione di aziende farmaceutiche con una visione condivisa di fornire test completi a tutti i malati di cancro in tutto il mondo. Pertanto, la crescente applicazione in oncologia e altri disturbi guida la crescita del mercato della diagnostica di precisione.

Approfondimenti basati sul tipo

In base al tipo, il mercato della diagnostica di precisione è segmentato in test genetici, test esoterici, e altri.  Nel 2022, il segmento dei test genetici detiene la quota maggiore del mercato. Inoltre, si prevede che lo stesso segmento registrerà il CAGR più elevato, pari al 13,8% durante il periodo di previsione.

Mercato della diagnostica di precisione, per tipo: 2022 e 2028

Approfondimenti basati sull'applicazione

In base all'applicazione, il mercato della diagnostica di precisione è segmentato in oncologia, cardiologia, malattie respiratorie, immunologia e altri .  Il segmento oncologico detiene la quota di mercato maggiore nel 2022. Inoltre, si prevede che lo stesso segmento registrerà il CAGR più elevato, pari al 13,8%, durante il periodo di previsione.

Approfondimenti basati sugli utenti finali

In base all’utente finale, il mercato della diagnostica di precisione è segmentato in laboratori clinici, ospedali, assistenza domiciliare e altri. Il segmento dei laboratori clinici detiene la quota di mercato maggiore nel 2022. Inoltre, si prevede che lo stesso segmento registrerà il CAGR più elevato, pari al 13,8% durante il periodo di previsione.

Gli operatori del mercato della diagnostica di precisione si concentrano sull'adozione di strategie organiche, compreso il lancio e l'espansione dei prodotti, per espandere la propria presenza e il portafoglio di prodotti in tutto il mondo e soddisfare le crescenti richieste.

Per area geografica

In base alla geografia, il mercato della diagnostica di precisione è segmentato in Nord America ( Stati Uniti, Canada e Messico), Europa (Regno Unito, Germania, Francia, Italia, Spagna e resto d'Europa), Asia Pacifico (Cina, Giappone, India, Australia, Corea del Sud e resto dell'Asia Pacifico) , Medio Oriente e Medio Oriente Africa (Emirati Arabi Uniti, Arabia Saudita, Sud Africa e resto del Medio Oriente e dell'Africa) e Sud e Africa. America centrale (Brasile, Argentina e il resto dell'America meridionale e centrale).

Profili aziendali

  • Quest Diagnostics Incorporated
  • QIAGEN
  • Swiss Precision Diagnostics GmbH
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • Siemens Healthineers AG
  • Abbott
  • Novartis AG
  • Sanofi
  • Bayer AG
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is projected to be the fastest growing region in the global precision diagnostics market?

Asia Pacific is expected to be the fastest growing region in precision diagnostics market over the forecast period due to developing healthcare infrastructure, enormous population base, growing prevalence of chronic diseases, growing government efforts, and technological improvement in the sector.

Which region accounts for major market share in 2022 in global precision diagnostics market?

North America accounts for the major market share of precision diagnostics market in 2022 due to increasing prevalence of cancer and chronic cases in the region and increasing initiatives by government and companies operating in the country.

Which segment is dominating the precision diagnostics market based on type?

The colorectal cancer market is analyzed in the basis of type, application, and end user. Based on type, the market is segmented into genetic tests, esoteric tests, and others. The genetic tests segment held the largest share of the market. Moreover, the same segment is anticipated to register the highest CAGR in the forecast period.

What are the growth estimates for the precision diagnostics market till 2028?

The precision diagnostics market is expected to be valued at US$ 168,405.71 million in 2028.

What is the estimated precision diagnostics market size of the market in 2022?

The precision diagnostics market is estimated to be valued at US$ 79,776.88 million in 2022.

What will be the CAGR of the precision diagnostics market during the forecast period?

The market is estimated to grow at a CAGR of 13.3% during the forecast period.

Who are the major players in precision diagnostics market across the globe?

The precision diagnostics market majorly consists of the players, such as Quest Diagnostics Incorporated; QIAGEN; Swiss Precision Diagnostics GmbH; Koninklijke Philips N.V.; Lantheus Medical Imaging, Inc.; Siemens Healthineers AG; Abbott; Novartis AG; Sanofi; and Bayer AG.

What are the driving factors for the global precision diagnostics market across the world?

The factors that are driving the growth of market are increasing demands of precision medicines and rising application of precision diagnostics. However, high investments involved in the R&D of precision medicine and diagnostic kits is the major factor hindering the precision diagnostics market growth.

What is precision diagnostics?

Precision diagnostics are disease diagnosis methods that explain the patient’s condition in a detailed and precise manner. It helps healthcare professionals to carry out treatment procedures in an effective and efficient manner. It is used to cure diabetes, cancer, and other disorders using various diagnostics tests.

The List of Companies - Precision Diagnostics Market

  1. Quest Diagnostics Incorporated
  2. QIAGEN
  3. Swiss Precision Diagnostics GmbH
  4. Koninklijke Philips N.V.
  5. Lantheus Medical Imaging, Inc.
  6. Siemens Healthineers AG
  7. Abbott
  8. Novartis AG
  9. Sanofi
  10. Bayer AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports